🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

W. Jeffrey Petty

Atrium Health Wake Forest Baptist

ORCID: 0000-0002-1553-1838

Also affiliated with Wake Forest University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.379Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates

Frontiers in Oncology(2021)10.3389/fonc.2021.584896
Top 48%
0.379DataRank
Top 48%5 citations

Lynn S. Huang, Ryan Barnard, Graham Parks, James O. Cappellari, Christina Bellinger +11 more

Papers

Driven by 12 papers — median percentile 52. Top paper: “SMARCA4 mutations in KRAS ‐mutant lung adenocarcinoma: a multi‐cohort analysis”.

SMARCA4 mutations in KRAS ‐mutant lung adenocarcinoma: a multi‐cohort analysis

Molecular Oncology(2020)10.1002/1878-0261.12831
N/A
2.4DataRank · unranked
59 citations

Tamjeed Ahmed, W. Jeffrey Petty, Stefan C. Grant, Jimmy Ruiz, Thomas Lycan +12 more

Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2023.4025
N/A
1.1DataRank · unranked
48 citations

Zhonglin Hao, Liza C. Villaruz, Jun Zhang, Jimmy Ruiz, W. Jeffrey Petty +33 more

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates

Frontiers in Oncology(2021)10.3389/fonc.2021.584896
Top 48%
0.379DataRank
Top 48%5 citations

Lynn S. Huang, Ryan Barnard, Graham Parks, James O. Cappellari, Christina Bellinger +11 more

Aerosolized immunotherapeutic nanoparticle inhalation potentiates PD-L1 blockade for locally advanced lung cancer

Nano Research(2022)10.1007/s12274-022-5205-6
N/A
0DataRank · unranked
28 citations

William Crowe, Lulu Wang, W. Jeffrey Petty, Amyn A. Habib, Dawen Zhao +1 more

Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report

Lung Cancer(2023)10.1016/j.lungcan.2023.107400
N/A
0DataRank · unranked
3 citations

Chance Bloomer, Wei Zhang, W. Jeffrey Petty, Lauren Schmalz

Genomic Signature for Oligometastatic Disease in Non-Small Cell Lung Cancer Patients with Brain Metastases

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.476
N/A
0DataRank · unranked
0 citations

Ralph B. D’Agostino, Michael Farris, M. Abdulhaleem, Yuan Wang, M. D. Smith +12 more

The association between an electronic health record (EHR)–embedded frailty index and patient-reported outcomes among patients with metastatic non–small-cell lung cancer on immunotherapy.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.335
N/A
0DataRank · unranked
0 citations

Laurie E. McLouth, Beverly J. Levine, Thomas Lycan, Jimmy Ruiz, Michael Farris +8 more

Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.10.021
N/A
0DataRank · unranked
32 citations

Jieling Miao, Karen L. Reckamp, Carl M. Gay, Lauren A. Byers, Ying‐Qi Zhao +15 more

Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance

Cancer(2024)10.1002/cncr.35663
N/A
0DataRank · unranked
3 citations

Briant Fruth, Andreas Rimner, Saiama N. Waqar, M. Mix, W. Jeffrey Petty +5 more

Implementation and Retrospective Examination of a Lung Cancer Survivorship Clinic in a Comprehensive Cancer Center

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.09.008
N/A
0DataRank · unranked
2 citations

Alana Willis, Amy Hensley, Jill Hyson, Stephanie J. Sohl, Ralph B. D’Agostino +6 more

The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer

Contemporary Clinical Trials(2020)10.1016/j.cct.2020.105963
N/A
0DataRank · unranked
16 citations

David P. Miller, Kathryn E. Weaver, Erin L. Sutfin, W. Jeffrey Petty, Christina Bellinger +8 more

Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8505
N/A
0DataRank · unranked
37 citations

Xiaofei F. Wang, Gregory A. Masters, Junheng Gao, Ritsuko Komaki, Charles Kuzma +8 more